Cytotech Pharmaceuticals Private Limited
About Cytotech Pharmaceuticals Private Limited
Data last updated:
Cytotech Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 18 September 2008.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC061113. Its GSTIN is 36AADCC5020G1Z4 (Telangana).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Shalini Thakur and Jeetendra Kumar Swain.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2018, the company reported a revenue of ₹13.96 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹18,768 (net margin 1.3%) and EBITDA of ₹2.34 Lakh (EBITDA margin 16.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.
Company details
CIN history
Cytotech Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2008PTC061113. The current CIN is U24232TG2008PTC061113, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008PTC061113 | Current |
| U24232AP2008PTC061113 | Previous |
Contact details
Cytotech Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressDoor. No. 8 – 52/A Srinivasa Nagar Chintal Hmt Road Quthubullapoor (Manda, L), Hyderabad, Telangana, India – 500054
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cytotech Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cytotech Pharmaceuticals Private Limited, buy the company report.
Financials of Cytotech Pharmaceuticals Private Limited
FY 2018 filings availableCytotech Pharmaceuticals Private Limited reported revenue of ₹13.96 Lakh (up 205% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 205% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 9%. EBITDA rose 286% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.34 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹18,768 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 16.8% | |||
| Net Profit Margin | 1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cytotech Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cytotech Pharmaceuticals Private Limited
Cytotech Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalini Thakur | Director | 18 Sep 2008 | 18 Years 1 Months | As last reported |
| Jeetendra Kumar Swain Also directs: Bless Pharma India Private Limited | Director | 18 Sep 2008 | 18 Years 1 Months | As last reported |
Legal cases
No court or tribunal cases involving Cytotech Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cytotech Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cytotech Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCC5020G1Z4 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cytotech Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cytotech Pharmaceuticals Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Jeetendra Kumar Swain was appointed as Director on 18 Sep 2008.
Frequently asked questions
Cytotech Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Cytotech Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 18 September 2008 and is registered under CIN U24232TG2008PTC061113. The company has been struck off by the Registrar of Companies and is no longer operational.
Cytotech Pharmaceuticals had 2 directors:
- Shalini Thakur - Director
- Jeetendra Kumar Swain - Director
The CIN (Corporate Identification Number) of Cytotech Pharmaceuticals is U24232TG2008PTC061113. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Cytotech Pharmaceuticals is at Door. No. 8 – 52A Srinivasa Nagar Chintal Hmt Road Quthubullapoor Manda, L, Hyderabad, Telangana, India – 500054.
Cytotech Pharmaceuticals was incorporated on 18 September 2008. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Cytotech Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
The GSTIN of Cytotech Pharmaceuticals is 36AADCC5020G1Z4, registered in Telangana.
Cytotech Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Jeetendra Kumar Swain was appointed as Director on 18 Sep 2008. Shalini Thakur was appointed as Director on 18 Sep 2008.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
